Genmab's CEO pulls in DKK 37.3m salary – has shares worth DKK 1.6bn

Following an outstandingly profitable year for Genmab, CEO Jan van de Winkel got a pay raise, bringing his annual salary to DKK 37.3m. The CEO also owns a lucrative set of shares, which had a total market value of DKK 1.6bn at end-2020.
Genmab CEO Jan van de Winkel | Photo: Mik Eskestad/Jyllands-Posten/Ritzau Scanpix
Genmab CEO Jan van de Winkel | Photo: Mik Eskestad/Jyllands-Posten/Ritzau Scanpix
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN

This year, money has once again rained down on Genmab's Dutch Chief Executive Officer Jan van de Winkel, after 2020 proved to be an outstandingly profitable fiscal year for the company. Its revenue succeeded the predicted DKK 10.1bn (USD 1.65bn).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading